methotrexate has been researched along with Liver Steatosis in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (54.55) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (12.12) | 29.6817 |
2010's | 11 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chonprasertsuk, S; Lertnawapan, R; Siramolpiwat, S | 1 |
Pais, R; Ratziu, V; Rusu, E | 1 |
Amacher, DE; Chalasani, N | 1 |
Collins, P; Higgins, E; Kirby, B; Lally, A; Lynch, M; McCormick, PA; Nolan, N; Omar, H; Rogers, S; Vellinga, A | 1 |
Büning, J; Fellermann, K; Lehnert, H; Mackenroth, T; Möller, S; Olsen, V; Schmidt, KJ; Schröder, T; Sina, C | 1 |
Vinken, M | 1 |
Guo, GL; Schumacher, JD | 1 |
Ferrazzi, A; Girolomoni, G; Gisondi, P | 1 |
Aghdassi, E; Fortin, PR; Gladman, DD; Hirschfield, GM; Huang, D; Mosko, J; Su, J; Urowitz, MB | 1 |
Larrain, S; Rinella, ME | 1 |
Abritta, G; Cravero, A; Enriquez, N; Martínez Artola, Y; Ortiz, V; Palermo, C; Poncino, D; Rosenberg, S; Santiago García, D; Saturansky, E | 1 |
Campbell, MS; Reddy, KR | 1 |
Burt, AD; Leong, MY; Mathew, J; Morley, N | 1 |
Flechtenmacher, C; Longerich, T; Schirmacher, P | 1 |
Chung, H; Hong, I; Kang, KS; Kim, HL; Kim, JH; Kim, M; Kong, G; Lee, BH; Lee, MH; Lee, MO; Yoon, BI | 1 |
Zimmerman, HJ | 2 |
Allen, RM; Bloomer, JR; Klatskin, G; Kobayashi, K | 1 |
Custer, RP; Freeman-Narrod, M; Narrod, SA | 2 |
Clegg, DO; Furst, DE; Pogue, R; Tolman, KG | 1 |
Aponte, J; Petrelli, M | 1 |
Kollberg, B; Sandstedt, B; Szanto, E | 1 |
Mackenzie, AH | 1 |
Sogaard, H; Zachariae, H | 1 |
Kirchmayer, S | 1 |
Aach, RD; Eisen, AZ; Grisham, JW; Reese, LT | 1 |
Tashima, CK | 1 |
Dabels, J; Diwok, K; Leithäuser, W; Moldenhauer, E; Nowotny, P | 1 |
Akerman, M; Berge, G; Lundquist, A; Rorsman, H | 1 |
Holst, R; Mobacken, H | 1 |
Cox, JW; Frost, P; Kalser, M; Millard, MM; Suringa, DW; Weinstein, GD | 1 |
Dahl, MG; Gregory, MM; Scheuer, PJ | 1 |
9 review(s) available for methotrexate and Liver Steatosis
Article | Year |
---|---|
The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease.
Topics: Acetaminophen; Anesthetics; Animals; Chemical and Drug Induced Liver Injury; Fatty Liver; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Insulin Resistance; Male; Metabolic Syndrome; Methotrexate; Non-alcoholic Fatty Liver Disease; Obesity; Prevalence; Risk Factors; Trans-Activators; Viral Regulatory and Accessory Proteins | 2014 |
Drug-induced hepatic steatosis.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Anti-Retroviral Agents; Anticholesteremic Agents; Anticonvulsants; Antineoplastic Agents, Hormonal; Drug Evaluation, Preclinical; Fatty Liver; Humans; Immunosuppressive Agents; Lysosomal Storage Diseases; Methotrexate; Mitochondria, Liver; Phospholipids; Tamoxifen; Valproic Acid | 2014 |
Adverse Outcome Pathways and Drug-Induced Liver Injury Testing.
Topics: Bosentan; Chemical and Drug Induced Liver Injury; Cholestasis; Fatty Liver; Humans; Liver Cirrhosis; Methotrexate; Quantitative Structure-Activity Relationship; Sulfonamides; Valproic Acid | 2015 |
Mechanistic review of drug-induced steatohepatitis.
Topics: Amiodarone; Animals; Camptothecin; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Fatty Liver; Hepatocytes; Humans; Irinotecan; Lipid Metabolism; Liver; Methotrexate; Mitochondria, Liver; Organoplatinum Compounds; Oxaliplatin; Perhexiline; Tamoxifen; Tetracycline; Valproic Acid | 2015 |
Metabolic comorbidities and psoriasis.
Topics: Arthritis, Psoriatic; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Dyslipidemias; Fatty Liver; Humans; Hypertriglyceridemia; Immunosuppressive Agents; Insulin Resistance; Metabolic Syndrome; Methotrexate; Non-alcoholic Fatty Liver Disease; Obesity; Psoriasis; Risk Factors | 2010 |
A myriad of pathways to NASH.
Topics: Amiodarone; Anti-Retroviral Agents; Bacterial Infections; Cannabis; Diet; Fatty Liver; Genetic Diseases, Inborn; Glucocorticoids; Humans; Hypothyroidism; Insulin Resistance; Intestinal Diseases; Lipid Metabolism; Metabolic Syndrome; Methotrexate; Non-alcoholic Fatty Liver Disease; Occupational Diseases; Perhexiline | 2012 |
Review article: the evolving role of liver biopsy.
Topics: Biopsy; Chemical and Drug Induced Liver Injury; Fatty Liver; Hepatitis B; Hepatitis C; Humans; Liver; Methotrexate | 2004 |
[Quality and quantity in hepatopathology. Diagnostic and clinically relevant grading for non-tumourous liver diseases].
Topics: Fatty Liver; Female; Humans; Liver; Liver Diseases; Liver Transplantation; Male; Methotrexate; Necrosis | 2008 |
Drug-induced chronic hepatic disease.
Topics: Carcinoma, Hepatocellular; Chemical and Drug Induced Liver Injury; Chronic Disease; Fatty Liver; Hemangioendothelioma; Hexestrol; Humans; Hypertension, Portal; Liver; Liver Cirrhosis; Liver Neoplasms; Methotrexate; Necrosis; Oxyphenisatin Acetate | 1979 |
24 other study(ies) available for methotrexate and Liver Steatosis
Article | Year |
---|---|
Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
Topics: Adult; Aged; Alanine Transaminase; Antirheumatic Agents; Arthritis, Rheumatoid; Body Mass Index; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Elasticity Imaging Techniques; Fatty Liver; Female; Humans; Liver Cirrhosis; Male; Metabolic Syndrome; Methotrexate; Middle Aged; Predictive Value of Tests; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome | 2019 |
The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Biomarkers; Biopsy; Body Mass Index; Chemical and Drug Induced Liver Injury; Drug Monitoring; Elasticity Imaging Techniques; Fatty Liver; Female; Fibrosis; Humans; Immunosuppressive Agents; Liver; Male; Methotrexate; Middle Aged; Peptide Fragments; Procollagen; Psoriasis; Young Adult | 2014 |
Liver steatosis is a risk factor for hepatotoxicity in patients with inflammatory bowel disease under immunosuppressive treatment.
Topics: Adolescent; Adult; Age Factors; Aged; Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Body Mass Index; Chemical and Drug Induced Liver Injury; Colitis, Ulcerative; Crohn Disease; Fatty Liver; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Sex Factors; Ultrasonography; Young Adult | 2015 |
Prevalence and risk factors for liver biochemical abnormalities in Canadian patients with systemic lupus erythematosus.
Topics: Adult; Alanine Transaminase; Antibodies, Neutralizing; Antiphospholipid Syndrome; Aspartate Aminotransferases; Autoimmune Diseases; Azathioprine; Body Mass Index; Canada; DNA; Fatty Liver; Female; Humans; Hypertension; Immunosuppressive Agents; Liver; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Prevalence; Risk Factors; Severity of Illness Index; Ultrasonography | 2012 |
[Liver diseases in rheumatoid and psoriatic arthritis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Psoriatic; Arthritis, Rheumatoid; Chemical and Drug Induced Liver Injury; Cohort Studies; Cross-Sectional Studies; Fatty Liver; Female; Humans; Male; Methotrexate; Middle Aged; Obesity; Risk Factors | 2012 |
A liver fibrosis cocktail? Psoriasis, methotrexate and genetic hemochromatosis.
Topics: Dermatologic Agents; Fatty Liver; Fibrosis; Hemochromatosis; Humans; Liver; Male; Methotrexate; Middle Aged; Psoriasis; Risk Factors | 2005 |
Gene expression profiles of murine fatty liver induced by the administration of methotrexate.
Topics: Administration, Oral; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Liver; Gene Expression; Gene Expression Profiling; Lipid Metabolism; Male; Methotrexate; Mice; Mice, Inbred ICR; Oligonucleotide Array Sequence Analysis; RNA, Messenger; Toxicogenetics | 2008 |
Enzymatic fluorometry for estimating serum total bile acid concentration.
Topics: 3-Hydroxysteroid Dehydrogenases; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Fasting; Fatty Liver; Female; Fluorometry; Hepatitis, Viral, Human; Humans; Liver; Liver Diseases; Male; Methotrexate; Necrosis; Sarcoidosis | 1979 |
Hepatotoxicity in Wistar rats following chronic methotrexate administration: a model of human reaction.
Topics: Age Factors; Animals; Body Weight; Bone Marrow; Digestive System; Fatty Liver; Humans; Liver; Lung; Lymphocytes; Male; Methotrexate; Necrosis; Rats; Skin; Spleen; Testis; Triglycerides | 1977 |
Chronic toxicity of methotrexate in rats: partial to complete projection of the liver by choline: Brief communication.
Topics: Animals; Bone Marrow; Choline; Choline Deficiency; Fatty Liver; Liver; Male; Methotrexate; Rats | 1977 |
Liver disease caused by medicinal agents.
Topics: Adrenal Cortex Hormones; Analgesics; Chemical and Drug Induced Liver Injury; Cholestasis; Contraceptive Agents; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Fatty Liver; Halothane; Humans; Isoniazid; Jaundice; Liver; Liver Cirrhosis; Metabolism, Inborn Errors; Methotrexate; Methoxyflurane; Methyldopa; Necrosis; Novobiocin | 1975 |
Acute, reversible hepatic failure associated with methotrexate treatment of rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Ascites; Chemical and Drug Induced Liver Injury, Chronic; Fatty Liver; Female; Hepatitis, Chronic; Humans; Liver Cirrhosis; Methotrexate; Middle Aged | 1989 |
Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Chemical and Drug Induced Liver Injury; Fatty Liver; Female; Humans; Liver Cirrhosis; Liver Diseases; Male; Methotrexate; Middle Aged; Time Factors | 1988 |
Hepatotoxicity associated with low-dose, long-term methotrexate treatment of rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Biopsy; Chemical and Drug Induced Liver Injury; Fatty Liver; Female; Humans; Liver; Liver Diseases; Liver Function Tests; Male; Methotrexate; Middle Aged; Time Factors | 1987 |
Hepatotoxicity of prolonged methotrexate therapy for rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Biopsy; Chemical and Drug Induced Liver Injury; Fatty Liver; Female; Humans; Liver; Liver Diseases, Alcoholic; Liver Function Tests; Male; Methotrexate; Middle Aged; Sjogren's Syndrome | 1985 |
Liver biopsy in psoriasis. A controlled study.
Topics: Administration, Oral; Alcoholism; Biopsy; Fatty Liver; Humans; Injections; Liver; Methotrexate; Psoriasis | 1973 |
[Drug-induced hepatopathies].
Topics: Adult; Age Factors; Bilirubin; Cell Membrane; Chemical and Drug Induced Liver Injury; Cholestasis; Drug Hypersensitivity; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Fatty Liver; Female; Halothane; Humans; Infant, Newborn; Liver; Liver Cirrhosis; Male; Methotrexate; Microsomes, Liver; Pharmaceutical Preparations; Pregnancy; Tetracycline | 1974 |
Effects of methotrexate on the liver in psoriasis.
Topics: Biopsy; Cell Nucleus; Chemical and Drug Induced Liver Injury; Ethanol; Fatty Liver; Follow-Up Studies; Humans; Liver; Liver Cirrhosis; Liver Function Tests; Methotrexate; Necrosis; Psoriasis; Sulfobromophthalein | 1974 |
Methotrexate and hepatic disease.
Topics: Aged; Chemical and Drug Induced Liver Injury; Fatty Liver; Female; Humans; Liver; Liver Cirrhosis; Methotrexate; Psoriasis | 1971 |
[Liver changes in psoriasis vulgaris].
Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; Fatty Liver; Female; Humans; Liver; Liver Function Tests; Male; Methotrexate; Middle Aged; Psoriasis; Sulfobromophthalein | 1971 |
Liver biopsy in psoriasis.
Topics: Adult; Aged; Alcoholism; Biopsy; Chemical and Drug Induced Liver Injury; Fatty Liver; Female; Humans; Liver; Liver Cirrhosis; Liver Diseases; Male; Methotrexate; Middle Aged; Obesity; Psoriasis; Transaminases | 1970 |
[Liver damage during methotrexate treatment of psoriasis].
Topics: Adult; Biopsy; Fatty Liver; Female; Humans; Liver Function Tests; Male; Methotrexate; Middle Aged; Psoriasis; Time Factors | 1970 |
Evaluation of possible chronic hepatotoxicity from methotrexate for psoriasis.
Topics: Adult; Aged; Alcohol Drinking; Biopsy; Chemical and Drug Induced Liver Injury; Fatty Liver; Female; Humans; Liver; Liver Cirrhosis; Liver Function Tests; Male; Methotrexate; Middle Aged; Necrosis; Psoriasis; Sulfobromophthalein | 1970 |
Liver damage due to methotrexate in patients with psoriasis.
Topics: Adult; Aged; Biopsy; Cell Nucleus; Fatty Liver; Humans; Liver; Liver Cirrhosis; Liver Function Tests; Methotrexate; Middle Aged; Psoriasis; Sulfobromophthalein | 1971 |